Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the mycobacterium tuberculosis beijing genotype

Infection and Immunity

Volumn 81, Issue 10, 2013, Pages 3750-3756

  van Laarhoven, Arjan ^a   Mandemakers, Jornt J ^b   Kleinnijenhuis, Johanneke ^a   Enaimi, Mimount ^c   Lachmandas, Ekta ^a   Joosten, Leo A B ^a   Ottenhoff, Tom H M ^d   Netea, Mihai G ^a   van Soolingen, Dick ^a,c   van Crevel, Reinout ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CELL LYSATE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EX VIVO STUDY; GENOTYPE; HOST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; BIOLOGICAL EVOLUTION; CHINA; CYTOKINES; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; LEUKOCYTES, MONONUCLEAR; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 84884392061     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00282-13     Document Type: Article

References (38)

1. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F, Qing HZ, Enkhsaikan D, Nymadawa P, van Embden JD. 1995. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J. Clin. Microbiol. 33:3234-3238.
2. Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, Homolka S, Roach JC, Kremer K, Petrov DA, Feldman MW, Gagneux S. 2008. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol. 6:e311. doi:10.1371/journal.pbio.0060311.
3. Parwati I, van Crevel R, van Soolingen D. 2010. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect. Dis. 10:103-111.
4. Cobelens F. 2012. Relative reproductive fitness of the W-Beijing genotype. Int. J. Tuberc. Lung Dis. 16:287.
5. Mokrousov I, Narvskaya O, Otten T, Vyazovaya A, Limeschenko E, Steklova L, Vyshnevskyi B. 2002. Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia. Res. Microbiol. 153:629-637.
6. Schürch AC, Kremer K, Warren RM, Hung NV, Zhao Y, Wan K, Boeree MJ, Siezen RJ, Smith NH, van Soolingen D. 2011. Mutations in the regulatory network underlie the recent clonal expansion of a dominant subclone of the Mycobacterium tuberculosis Beijing genotype. Infect. Genet. Evol. 11:587-597.
7. Kremer K. 2009. Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains. Emerg. Infect. Dis. 15:335-339.
8. Mokrousov I, Jiao WW, Valcheva V, Vyazovaya A, Otten T, Ly HM, Lan NN, Limeschenko E, Markova N, Vyshnevskiy B, Shen AD, Narvskaya O. 2006. Rapid detection of the Mycobacterium tuberculosis Beijing genotype and its ancient and modern sublineages by IS6110-based inverse PCR. J. Clin. Microbiol. 44:2851-2856.
9. Dou H-Y, Tseng F-C, Lin C-W, Chang J-R, Sun J-R, Tsai W-S, Lee S-Y, Su I-J, Lu J-J. 2008. Molecular epidemiology and evolutionary genetics of Mycobacterium tuberculosis in Taipei. BMC Infect. Dis. 8:170. doi:10.1186/1471-2334-8-170.
10. Strauss OJ, Warren RM, Jordaan A, Streicher EM, Hanekom M, Falmer AA, Albert H, Trollip A, Hoosain E, van Helden PD, Victor TC. 2008. Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. J. Clin. Microbiol. 46:1514-1516.
11. Kato-Maeda M, Kim EY, Flores L, Jarlsberg LG, Osmond D, Hopewell PC. 2010. Differences among sublineages of the East-Asian lineage of Mycobacterium tuberculosis in genotypic clustering. Int. J. Tuberc. Lung Dis. 14:538-544.
12. Iwamoto T, Fujiyama R, Yoshida S, Wada T, Shirai C, Kawakami Y. 2009. Population structure dynamics of Mycobacterium tuberculosis Beijing strains during past decades in Japan. J. Clin. Microbiol. 47:3340-3343.
13. Wada T, Fujihara S, Shimouchi A, Harada M, Ogura H, Matsumoto S, Hase A. 2009. High transmissibility of the modern Beijing Mycobacterium tuberculosis in homeless patients of Japan. Tuberculosis 89:252-255.
14. Ioerger TR, Feng Y, Chen X, Dobos KM, Victor TC, Streicher EM, Warren RM, van Pittius NCG, van Helden PD, Sacchettini JC. 2010. The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa. BMC Genomics 11:670. doi:10.1186/1471-2164-11-670.
15. Mokrousov I, Jiao W-W, Sun G-Z, Liu J-W, Valcheva V, Li M, Narvskaya O, Shen A-D. 2006. Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype. Antimicrob. Agents Chemother. 50:2820-2823.
16. Jiao W-W, Mokrousov I, Sun G-Z, Li M, Liu J-W, Narvskaya O, Shen A-D. 2007. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin. Med. J. 120:814-819.
17. Plikaytis BB, Marden JL, Crawford JT, Woodley CL, Butler WR, Shinnick TM. 1994. Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis. J. Clin. Microbiol. 32:1542-1546.
18. Dysvik B, Jonassen I. 2001. J-Express: exploring gene expression data using Java. Bioinformatics 17:369-370.
19. Cooper AM, Mayer-Barber KD, Sher A. 2011. Role of innate cytokines in mycobacterial infection. Mucosal Immunol. 4:252-260.
20. van Crevel R, OttenhoffTHM, van der Meer JWM. 2002. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15:294-309.
21. OttenhoffTHM, Verreck FAW, Lichtenauer-Kaligis EGR, Hoeve MA, Sanal O, van Dissel JT. 2002. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 32:97-105.
22. OttenhoffTHM. 2012. New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol. 20:419-428.
23. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345:1098-1104.
24. Miller EA, Ernst JD. 2008. Illuminating the black box of TNF action in tuberculous granulomas. Immunity 29:175-177.
25. Flynn JL, Chan J, Lin PL. 2011. Macrophages and control of granulomatous inflammation in tuberculosis. Mucosal Immunol. 4:271-278.
26. Torrado ED, Cooper AM. 2010. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev. 21:455-462.
27. Davis JM, Ramakrishnan L. 2009. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136:37-49.
28. Glader P, Smith ME, Malmhäll C, Balder B, Sjöstrand M, Qvarfordt I, Lindén A. 2010. Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin. Eur. Respir. J. 36:1155-1164.
29. Sonnenberg GF, Fouser LA, Artis D. 2011. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12:383-390.
30. Portevin D, Gagneux S, Comas I, Young D. 2011. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog. 7:e1001307. doi:10.1371/journal.ppat.1001307.
31. Coscolla M, Gagneux S. 2010. Does M. tuberculosis genomic diversity explain disease diversity? Drug Discov. Today Dis. Mech. 7:e43-e59.
32. Gagneux S, Small PM. 2007. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 7:328-337.
33. Wang C, Peyron P, Mestre O, Kaplan G, van Soolingen D, Gao Q, Gicquel B, Neyrolles O. 2010. Innate immune response to Mycobacterium tuberculosis Beijing and other genotypes. PLoS One 5:e13594. doi: 10.1371/journal.pone.0013594.
34. Chacón-Salinas R, Serafín-López J, Ramos-Payán R, Méndez-Aragón P, Hernandez-Pando R, van Soolingen D, Flores-Romo L, Estrada-Parra S, Estrada-García I. 2005. Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 140:443-449.
35. Cappelli G, Volpe P, Sanduzzi A, Sacchi A, Colizzi V, Mariani F. 2001. Human macrophage gamma interferon decreases gene expression but not replication of Mycobacterium tuberculosis: analysis of the host-pathogen reciprocal influence on transcription in a comparison of strains H37Rv and CMT97. Infect. Immun. 69:7262-7270.
36. Krishnan N, Malaga W, Constant P, Caws M, Thi Hoang Chau T, Salmons J, Thi Ngoc Lan N, Bang ND, Daffé M, Young DB, Robertson BD, Guilhot C, Thwaites GE. 2011. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS One 6:e23870. doi:10.1371/journal.pone.0023870.
37. Kato-Maeda M, Shanley CA, Ackart D, Jarlsberg LG, Shang S, Obregon-Henao A, Harton M, Basaraba RJ, Henao-Tamayo M, Barrozo JC, Rose J, Kawamura LM, Coscolla M, Fofanov VY, Koshinsky H, Gagneux S, Hopewell PC, Ordway DJ, Orme IM. 2012. Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig. Clin. Vaccine Immunol. 19:1227-1237.
38. Mihret A, Bekele Y, Loxton AG, Aseffa A, Howe R, Walzl G. 2012. Plasma level of IL-4 differs in patients infected with different modern lineages of M. tuberculosis. J. Trop. Med. 2012:518564. doi:10.1155/2012/518564